Literature DB >> 19295409

Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas.

Yenlin Huang1, Anne Moreau, Jehan Dupuis, Berthold Streubel, Barbara Petit, Steven Le Gouill, Nadine Martin-Garcia, Christiane Copie-Bergman, Fanny Gaillard, Marwan Qubaja, Bettina Fabiani, Giovanna Roncador, Corinne Haioun, Marie-Hélène Delfau-Larue, Teresa Marafioti, Andreas Chott, Philippe Gaulard.   

Abstract

Rare cases of peripheral T-cell lymphomas with follicular growth pattern (PTCL-F) have been recently reported, and their association with t(5;9)(q33;q22) involving ITK and SYK has been suggested. However, the clinicopathologic aspects of PTCL-F are poorly described and the normal cell counterpart of this subgroup of lymphoma is still unknown. Therefore, we analyzed the pathologic, phenotypic, and cytogenetic features of a series of 30 patients (range: 33 to 88 y) that showed histopathologic features of PTCL-F in at least 1 biopsy (n=30), either at initial presentation (n=26) or at relapse (n=4). Neoplastic cells were medium-sized clear cells that were CD4+ (24/27, 89%), CD10+ (21/29, 72%), BCL-6+ (14/19, 74%), and expressed programed death-1 (27/27, 100%), CXCL13 (23/27, 85%), and ICOS (11/11, 100%), markers of follicular helper T cells (TFH). Four of 22 patients (18%) had t(5;9)(q33;q22) detected by fluorescence in situ hybridization. Patients with clinical data available had multiple lymphadenopathies (25/28, 89%), stage III to IV diseases (17/26, 65%), B symptoms (7/27, 26%), and skin lesions (6/23, 26%). Three patients with sequential biopsies disclosed clinical and histopathologic features of angioimmunoblastic T-cell lymphoma at initial presentation. Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295409      PMCID: PMC4838638          DOI: 10.1097/PAS.0b013e3181971591

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  44 in total

1.  Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma?

Authors:  T Rüdiger; R Ichinohasama; M M Ott; S Müller-Deubert; I Miura; G Ott; H K Müller-Hermelink
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

2.  Peripheral T-cell lymphoma with a "follicular" pattern and the perifollicular sinus phenotype.

Authors:  Liuyan Jiang; Dan Jones; L Jeffrey Medeiros; Y Rocio Orduz; Carlos E Bueso-Ramos
Journal:  Am J Clin Pathol       Date:  2005-03       Impact factor: 2.493

3.  Peripheral T-cell lymphoma with extensive dendritic cell network mimicking follicular dendritic cell tumor: a case report with pathologic, immunophenotypic, and molecular findings.

Authors:  Cindi R Starkey; Ayumi I Corn; Richard S Porensky; David Viswanatha; Carla S Wilson
Journal:  Am J Clin Pathol       Date:  2006-08       Impact factor: 2.493

Review 4.  T follicular helper (TFH) cells in normal and dysregulated immune responses.

Authors:  Cecile King; Stuart G Tangye; Charles R Mackay
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

5.  Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).

Authors:  Y Kuno; A Abe; N Emi; M Iida; T Yokozawa; M Towatari; M Tanimoto; H Saito
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

Review 6.  Pathobiology of peripheral T-cell lymphomas.

Authors:  Elaine S Jaffe
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

7.  Peripheral T-cell lymphoma with a nodular growth pattern.

Authors:  Ben Hatano; Takuya Fukushima; Miyuki Honda; Tomayoshi Hayashi; Nobuo Tsuda; Koichi Ohshima; Takeshi Tsuchiya; Masahiro Kikuchi
Journal:  Pathol Int       Date:  2002 May-Jun       Impact factor: 2.534

8.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

9.  Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.

Authors:  A L Feldman; D X Sun; M E Law; A J Novak; A D Attygalle; E C Thorland; S R Fink; J A Vrana; B L Caron; W G Morice; E D Remstein; K L Grogg; P J Kurtin; W R Macon; A Dogan
Journal:  Leukemia       Date:  2008-04-10       Impact factor: 11.528

10.  Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.

Authors:  A D Attygalle; S-S Chuang; T C Diss; M-Q Du; P G Isaacson; A Dogan
Journal:  Histopathology       Date:  2007-03       Impact factor: 5.087

View more
  44 in total

1.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

2.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

3.  A novel subset of T-helper cells: follicular T-helper cells and their markers.

Authors:  Camille Laurent; Nicolas Fazilleau; Pierre Brousset
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 4.  Follicular helper T cells: implications in neoplastic hematopathology.

Authors:  Philippe Gaulard; Laurence de Leval
Journal:  Semin Diagn Pathol       Date:  2011-08       Impact factor: 3.464

5.  Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Authors:  Marie-Hélène Delfau-Larue; Laurence de Leval; Bertrand Joly; Anne Plonquet; Dominique Challine; Marie Parrens; Alain Delmer; Gilles Salles; Franck Morschhauser; Richard Delarue; Pauline Brice; Reda Bouabdallah; Olivier Casasnovas; Hervé Tilly; Philippe Gaulard; Corinne Haioun
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 6.  Peripheral T cell lymphoma in Asia.

Authors:  Sanghui Park; Young Hyeh Ko
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

Review 7.  Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.

Authors:  Manabu Fujisawa; Shigeru Chiba; Mamiko Sakata-Yanagimoto
Journal:  J Clin Exp Hematop       Date:  2017

Review 8.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

9.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-09-26       Impact factor: 0.196

10.  Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.

Authors:  Alina Nicolae; Stefania Pittaluga; Girish Venkataraman; Anahi Vijnovich-Baron; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.